These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 9213002)

  • 1. Effect of rhBMP-2 on the osteogenic potential of bone marrow stromal cells from an osteogenesis imperfecta mouse (oim).
    Balk ML; Bray J; Day C; Epperly M; Greenberger J; Evans CH; Niyibizi C
    Bone; 1997 Jul; 21(1):7-15. PubMed ID: 9213002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. rhBMP-2 induces terminal differentiation of human bone marrow mesenchymal stromal cells only by synergizing with other signals.
    Kathami N; Moreno-Vicente C; Martín P; Vergara-Arce JA; Ruiz-Hernández R; Gerovska D; Aransay AM; Araúzo-Bravo MJ; Camarero-Espinosa S; Abarrategi A
    Stem Cell Res Ther; 2024 Apr; 15(1):124. PubMed ID: 38679735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galunisertib downregulates mutant type I collagen expression and promotes MSCs osteogenesis in pediatric osteogenesis imperfecta.
    Infante A; Alcorta-Sevillano N; Macías I; Cabodevilla L; Medhat D; Lafaver B; Crawford TK; Phillips CL; Bueno AM; Sagastizabal B; Arroyo M; Campino A; Gerovska D; Araúzo-Bravo M; Gener B; Rodríguez CI
    Biomed Pharmacother; 2024 Jun; 175():116725. PubMed ID: 38744219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased resorptive activity and accompanying morphological alterations in osteoclasts derived from the oim/oim mouse model of osteogenesis imperfecta.
    Zhang H; Doty SB; Hughes C; Dempster D; Camacho NP
    J Cell Biochem; 2007 Nov; 102(4):1011-20. PubMed ID: 17668424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparable outcomes in fracture reduction and bone properties with RANKL inhibition and alendronate treatment in a mouse model of osteogenesis imperfecta.
    Bargman R; Posham R; Boskey AL; DiCarlo E; Raggio C; Pleshko N
    Osteoporos Int; 2012 Mar; 23(3):1141-50. PubMed ID: 21901481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Col1A-2 Mutation in Osteogenesis Imperfecta Mice Contributes to Long Bone Fragility by Modifying Cell-Matrix Organization.
    André G; Chretien A; Demoulin A; Beersaerts M; Docquier PL; Behets C
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel human TGF-β1 fusion protein in combination with rhBMP-2 increases chondro-osteogenic differentiation of bone marrow mesenchymal stem cells.
    Claros S; Rico-Llanos GA; Becerra J; Andrades JA
    Int J Mol Sci; 2014 Jun; 15(7):11255-74. PubMed ID: 24968268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dickkopf-1 (DKK1) blockade mitigates osteogenesis imperfecta (OI) related bone disease.
    Ko JY; Wang FS; Lian WS; Yang FS; Chen JW; Huang PH; Liao CY; Kuo SJ
    Mol Med; 2024 May; 30(1):66. PubMed ID: 38773377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulating CXCR4 in human fetal mesenchymal stem cells enhances engraftment and bone mechanics in a mouse model of osteogenesis imperfecta.
    Jones GN; Moschidou D; Lay K; Abdulrazzak H; Vanleene M; Shefelbine SJ; Polak J; de Coppi P; Fisk NM; Guillot PV
    Stem Cells Transl Med; 2012 Jan; 1(1):70-8. PubMed ID: 23197643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurocranial growth in the OIM mouse model of osteogenesis imperfecta.
    Husain TS; Moore JC; Huston LA; Miller CA; Steele AT; Gonzales LA; Handler EK; Organ JM; Menegaz RA
    Anat Rec (Hoboken); 2024 Mar; 307(3):581-591. PubMed ID: 37638403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compromised Exercise Capacity and Mitochondrial Dysfunction in the Osteogenesis Imperfecta Murine (oim) Mouse Model.
    Gremminger VL; Jeong Y; Cunningham RP; Meers GM; Rector RS; Phillips CL
    J Bone Miner Res; 2019 Sep; 34(9):1646-1659. PubMed ID: 30908713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased cochlear otic capsule thickness and intracortical canal porosity in the oim mouse model of osteogenesis imperfecta.
    De Paolis A; Miller BJ; Doube M; Bodey AJ; Rau C; Richter CP; Cardoso L; Carriero A
    J Struct Biol; 2021 Jun; 213(2):107708. PubMed ID: 33581284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preventive effects of puerarin on alcohol-induced osteonecrosis.
    Wang Y; Yin L; Li Y; Liu P; Cui Q
    Clin Orthop Relat Res; 2008 May; 466(5):1059-67. PubMed ID: 18350350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble activin receptor type IIB decoy receptor differentially impacts murine osteogenesis imperfecta muscle function.
    Jeong Y; Daghlas SA; Kahveci AS; Salamango D; Gentry BA; Brown M; Rector RS; Pearsall RS; Phillips CL
    Muscle Nerve; 2018 Feb; 57(2):294-304. PubMed ID: 28555931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dental tissue changes in juvenile and adult mice with osteogenesis imperfecta.
    Moore JC; Husain TS; Huston LA; Steele AT; Organ JM; Gonzales LA; Menegaz RA; Handler EK
    Anat Rec (Hoboken); 2024 Mar; 307(3):600-610. PubMed ID: 37638385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-mechanics relationships of collagen fibrils in the osteogenesis imperfecta mouse model.
    Andriotis OG; Chang SW; Vanleene M; Howarth PH; Davies DE; Shefelbine SJ; Buehler MJ; Thurner PJ
    J R Soc Interface; 2015 Oct; 12(111):20150701. PubMed ID: 26468064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-Body Metabolism and the Musculoskeletal Impacts of Targeting Activin A and Myostatin in Severe Osteogenesis Imperfecta.
    Omosule CL; Joseph D; Weiler B; Gremminger VL; Silvey S; Lafaver BN; Jeong Y; Kleiner S; Phillips CL
    JBMR Plus; 2023 Jul; 7(7):e10753. PubMed ID: 37457877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Craniofacial dysmorphism of osteogenesis imperfecta mouse and effect of cathepsin K knockout: Preliminary craniometry observations.
    Fosséprez J; Roels T; Manicourt D; Behets C
    Morphologie; 2024 Sep; 108(362):100785. PubMed ID: 38788496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schnurri-3 inhibition rescues skeletal fragility and vascular skeletal stem cell niche pathology in a mouse model of osteogenesis imperfecta.
    Xu R; Li N; Shi B; Li Z; Han J; Sun J; Yallowitz A; Bok S; Xiao S; Wu Z; Chen Y; Xu Y; Qin T; Lin Z; Zheng H; Shen R; Greenblatt M
    Res Sq; 2023 Jul; ():. PubMed ID: 37546916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. AAV-based gene editing of type 1 collagen mutation to treat osteogenesis imperfecta.
    Yang YS; Sato T; Chaugule S; Ma H; Xie J; Gao G; Shim JH
    Mol Ther Nucleic Acids; 2024 Mar; 35(1):102111. PubMed ID: 38261950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.